Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12018030 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Patent 12018030 was granted and assigned to Valo Health on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David Joseph Guerin0

Minghua Wang0

Bruce Follows0

David R. Lancia, Jr.0

Justin Andrew Caravella0

Adam Charles Talbot0

Ann-Marie Campbell0

Darby Rye Schmidt0

...

Date of Patent

June 25, 2024

0

Patent Application Number

171869150

Date Filed

February 26, 2021

0

Patent Citations

US Patent 7288624 Inhibitors of interleukin-1β converting enzyme

0

US Patent 7557113 Substituted pyrrolo[3,2-d]pyrimidine derivatives

0

US Patent 7563808 Methods for treating cognitive impairments or dementia

0

US Patent 7601728 Bicyclic pyrrole derivatives

0

US Patent 7745447 Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists

0

US Patent 7772366 Inhibitors of interleukin-1β converting enzyme

0

US Patent 7790713 Inhibitors of interleukin-1β converting enzyme

0

US Patent 6943253 6-phenylpyrrolopyrimidinedione derivatives

0

...

Patent Primary Examiner

Jeffrey H Murray

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12018030 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool